New-look stroke aspiration catheter!
New-look stroke aspiration catheter!
Summary:
1. Company & Device: Irish company Perfuze. The catheter is the Millipede 088 Superbore aspiration catheter.
2. Purpose: The device is designed to treat large vessel occlusion (LVO) strokes by removing clots in a way that minimizes vessel damage — by “ingesting” the blood clot as opposed to carrying it through the patient’s blood vessels. According to Perfuze, this limits the risk of vessel damage or other procedure-related complications.
3. Trial Details: The MARRS trial enrolled 180 adult patients across the U.S. and Europe.
4. Primary Outcomes: The study focuses on successful reperfusion and symptomatic intracerebral hemorrhage within 24 hours post-treatment.
5. Regulatory Status: While Millipede 088 already has FDA clearance, Perfuze aims to use MARRS data for expanded approval.
6. Leadership Quotes: CEO Wayne Allen and principal investigator Dr. Raul Nogueira both praised the dedication of the medical teams and the bravery of the patients.
